Form 4: Director Srinivas Akkaraju Increases Scholar Rock Stake

Director Srinivas Akkaraju acquired 6,839 restricted stock units and 4,310 stock options in Scholar Rock Holding Corp.

Summary

• Director Srinivas Akkaraju was granted 6,839 restricted stock units (RSUs) on June 4, 2026.
• The director also received a stock option grant for 4,310 shares with an exercise price of $45.33.
• The RSUs vest on the earlier of June 15, 2027, or the date of the next Annual Meeting.
• The stock options vest on the earlier of the first anniversary of the grant or the date of the next Annual Meeting.
• Following these transactions, the director holds 27,971 shares directly and maintains indirect interests in over 6.8 million shares through affiliated funds.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.
• Continued commitment from a director with significant indirect ownership in the company.

Negatives

• Dilutive impact of new equity grants, though standard for director compensation.

Risks

• Vesting is subject to continued service, creating a dependency on the director's ongoing tenure.
• Market volatility could impact the value of the granted options and RSUs.

Future Outlook

The equity grants are subject to standard vesting schedules tied to service and the next Annual Meeting, indicating a focus on retention and long-term alignment.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices in the biotechnology sector to ensure board members remain incentivized to oversee long-term clinical and commercial milestones.

Comparison to Industry Standards

• The grant structure is consistent with standard director compensation packages for mid-cap biotechnology firms.
• Vesting periods tied to annual meetings are common practice to ensure board continuity.

Related Party Transactions

• The director is associated with Samsara Opportunity Fund, L.P. and Samsara BioCapital, L.P., which hold significant stakes in the issuer.

Stakeholder Impact

• Shareholders benefit from the alignment of director incentives with company performance.

Next Steps

• Vesting of RSUs on June 15, 2027 or the next Annual Meeting.
• Vesting of stock options on the first anniversary of the grant or the next Annual Meeting.

Key Dates

Keywords

Scholar Rock, SRRK, Insider Trading, Form 4, Equity Compensation, Srinivas Akkaraju